AtezolizumabImmune-mediated pancolitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1702卷 / 1期

关键词：

D O I：

10.1007/s40278-018-46161-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[1] AtezolizumabImmune-mediated myositis: case report
Reactions Weekly, 2019, 1769 (1) : 73 - 73
[2] AtezolizumabImmune-mediated hepatitis: case report
Reactions Weekly, 2020, 1834 (1) : 45 - 45
[3] AtezolizumabImmune-mediated maculopapular rash: case report
Reactions Weekly, 2024, 2038 (1) : 38 - 38
[4] AtezolizumabImmune-mediated bullous pemphigoid: case report
Reactions Weekly, 2023, 1979 (1) : 72 - 72
[5] AtezolizumabImmune-mediated hepatitis and acute liver failure: case report
Reactions Weekly, 2020, 1796 (1) : 48 - 48
[6] Amoxicillin/clavulanic acid/atezolizumabImmune-mediated colitis and lack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 55 - 55
[7] AtezolizumabImmune pneumonitis: case report
Reactions Weekly, 2018, 1702 (1) : 50 - 50
[8] AtezolizumabImmune related alopecia: case report
Reactions Weekly, 2019, 1754 (1) : 61 - 61
[9] DiclofenacIschaemic pancolitis: case report
Reactions Weekly, 2020, 1799 (1) : 153 - 153
[10] IpilimumabAutoimmune pancolitis: case report
Reactions Weekly, 2011, 1361 (1) : 26 - 26

← 1 2 3 4 5 →